PREFERAOB ONE owner Contact Information online
from Alaven Pharmaceutical LLC
PREFERAOB ONE
The mark consists of the wording "PREFERAOB ONE", in stylized font, wherein the letter "O", of the "OB" letter portion of the mark, encircles the letter "a" of the "PREFERA" letter portion of the mark, and wherein the word "ONE" is positioned below the letter "B" of the "OB" portion of the mark.
US serial number:85055113
Application filling date:Jun. 04, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Oct. 19, 2010
Publication date:Aug. 03, 2010
Standard character claim:No
Mark drawing type:3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Goods and services:For: Pharmaceutical preparations, namely, nutritional supplements comprising iron, docosahexaenoic acid, and other nutrients
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(a)
First Use: Mar
Services:Pharmaceutical preparations
namely
nutritional supplements comprising iron
docosahexaenoic acid
and other nutrients
Current owner owner name:Alaven Pharmaceutical LLC
Current owner owner address:Suite 428
200 North Cobb Parkway
Marietta,
GEORGIA
UNITED STATES
30062
Current owner legal entity type:LIMITED LIABILITY COMPANY
Current owner state or country:DELAWARE
Attorney name:Ashish D. Patel
Attorney email:trademarks@thompsonhine.com
Attorney docket number:076517.00066
Attorney email authorized:No
Correspondent name address:ASHISH D. PATEL
THOMPSON HINE LLP
10050 Innovation Drive, Suite 400
Miamisburg,
OHIO
UNITED STATES
45342-4934
Correspondent phone:404-541-2900
Correspondent email:trademarks@thompsonhine.com
IPdocket@thompsonhine.com
ash.patel@thompsonhine.com
ashley.pecora@thompsonhine.com
Correspondent fax:404-541-2905
Correspondent email authorized PREFERAOB ONE:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Aug. 03, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
